Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AMED | Common Stock | Options Exercise | $26.7K | +975 | +3.35% | $27.35 | 30.1K | May 28, 2021 | Direct | F1 |
transaction | AMED | Common Stock | Sale | -$255K | -975 | -3.24% | $261.60 | 29.1K | May 28, 2021 | Direct | F1, F2 |
holding | AMED | Common Stock | 2.71K | May 28, 2021 | Through 401(k) Plan | F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AMED | Stock Option (Right to Buy) | Options Exercise | $0 | -975 | -100% | $0.00* | 0 | May 28, 2021 | Common Stock | 975 | $27.35 | Direct | F4 |
Id | Content |
---|---|
F1 | The total amount of shares beneficially owned includes 887 shares held in an employee stock purchase plan account. |
F2 | These sales were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. |
F3 | The information in this report is based on a plan statement dated as of March 31, 2021. |
F4 | On May 1, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2018 were met, resulting in vesting of the option as to 5,625 shares (the "2018 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2018 Tranche Options vested on May 1, 2019 and two-thirds of the 2018 Tranche Options vested on May 1, 2020. After the transactions reported in this Form 4, all of the 2018 Tranche Options have been exercised. |